Challenges in the Management of Poorly Differentiated Neuroendocrine Tumors: A Comprehensive Clinical Approach

Natalia C*, Rondan M, Cecilia C and Gabriel K

Department of Clinical Oncology, School of Medicine, University of Uruguay, Uruguay

^*Correspondance to: Natalia Camejo 

 PDF  Full Text Case Report | Open Access

Abstract:

This manuscript addresses poorly differentiated Neuroendocrine Tumors (NETs), focusing on their complexity, clinical presentation, and diagnostic and therapeutic challenges. Despite their rarity, poorly differentiated NETs, including extrapulmonary small cell carcinomas, are notably aggressive, characterized by high mitotic rates and extensive necrosis. Commonly diagnosed in advanced stages, these tumors have a variable prognosis and are prone to early metastasis. The first clinical case examines a 39-year-old patient whose advanced and metastatic disease underscores the importance of personalized treatment and the need for ongoing research. The second case, focusing on a neuroendocrine carcinoma, illustrates the tumor's aggressiveness and tendency to metastasize, even after an initially positive response to treatment. The choice of FOLFIRI as a second-line treatment reflects the need for an adaptive and multidisciplinary therapeutic approach. The discussion highlights the diversity and complexity of NETs and the importance of early diagnosis. Treatment, tailored to the tumor's type, location, and grade, ranges from surgery and chemotherapy to radiotherapy, with an emphasis on platinum-based regimens and emerging immunotherapy. In conclusion, the manuscript emphasizes the need for careful management and continuous research to improve medical outcomes and the quality of life of patients with these challenging tumors.

Keywords:

Cite the Article:

Natalia C, Rondan M, Cecilia C, Gabriel K. Challenges in the Management of Poorly Differentiated Neuroendocrine Tumors: A Comprehensive Clinical Approach. Ann Clin Case Rep. 2023; 8: 2533..